Edesa Biotech Inc. Common Shares (EDSA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Edesa Biotech Inc. Common Shares, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$2.56
−2.66% today
Market cap
$36M
Overall quality
58/100
Kronos AI 30-day
+100.7%
8 of 8 simulated paths end higher
Edesa Biotech Inc. Common Shares (EDSA) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $36M. It trades at $2.56, down 2.66% today. Its overall quality score is 58 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +100.7% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $5.28 (+100.7%) |
| Likely range | +86.5% … +122.9% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 37 |
| Solvency | 88 |
| Growth | 50 |
| Overall | 58 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.